Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
Zhaoyun Liu(Tianjin Medical University General Hospital), Rong Fu(Tianjin Medical University General Hospital)
Cited by 5
Related Papers
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
|Journal of Clinical Oncology|2024|77
Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer
|PLoS ONE|2017|50
Protocatechuic Acid-Mediated miR-219a-5p Activation Inhibits the p66shc Oxidant Pathway to Alleviate Alcoholic Liver Injury
|Oxidative Medicine and Cellular Longevity|2019|30
Downregulation of Pim-2 induces cell cycle arrest in the G0/G1 phase via the p53-non-dependent p21 signaling pathway
|Oncology Letters|2018|19
Bim and VDAC1 are hierarchically essential for mitochondrial ATF2 mediated cell death
|Cancer Cell International|2015|18